These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5001942)

  • 1. Opsonic defect in patients with cystic fibrosis of the pancreas.
    Biggar WD; Holmes B; Good RA
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
    Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
    J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
    Fick RB; Naegel GP; Matthay RA; Reynolds HY
    J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
    Fick RB; Reynolds HY
    Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
    Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
    J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure and function of alveolar macrophages from cystic fibrosis patients.
    Thomassen MJ; Demko CA; Wood RE; Tandler B; Dearborn DG; Boxerbaum B; Kuchenbrod PJ
    Pediatr Res; 1980 May; 14(5):715-21. PubMed ID: 6770330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis of Pseudomonas aeruginosa by polymorphonuclear leukocytes and monocytes: effect of cystic fibrosis serum.
    Thomassen MJ; Demko CA; Wood RE; Sherman JM
    Infect Immun; 1982 Nov; 38(2):802-5. PubMed ID: 6815100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
    Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
    J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
    Hornick DB; Fick RB
    J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
    Speert DP; Eftekhar F; Puterman ML
    Infect Immun; 1984 Mar; 43(3):1006-11. PubMed ID: 6421734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
    Bender JG; Florman AL; Van Epps DE
    Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.
    Speert DP
    Surv Synth Pathol Res; 1985; 4(1):14-33. PubMed ID: 3927464
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa.
    Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR
    Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
    Reynolds HY; Kazmierowski JA; Newball HH
    J Clin Invest; 1975 Aug; 56(2):376-85. PubMed ID: 807599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
    Moss RB; Hsu YP; Sullivan MM; Lewiston NJ
    Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Pseudomonas heat-stable opsonins in acute lymphoblastic leukemia of childhood.
    Wollman MR; Young LS; Armstrong D; Haghbin M
    J Pediatr; 1975 Mar; 86(3):376-81. PubMed ID: 803559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.